glp 1 announcement today The Trump administration announced deals that will lower the prices of major obesity drugs for many Americans. Under the deals with Eli Lilly and Novo Nordisk, those buying injectable GLP-1 Trump Freezes as GLP-1 Patient

Lilly recently reported topline results from the ATTAIN-1 phase-3 trial evaluating orforglipron, a once-daily oral glucagon-like-peptide-1 (GLP-1) receptor agonist for adults with obesity or overweight without diabetes

However, body composition outcomes suffer significantly without resistance training

FOXO4-DRI FOXO4-DRI is a senolytic peptide designed to selectively induce apoptosis in senescent cells by disrupting the FOXO4-p53 interaction

Alyssa is also co-author of The Successful Mind: Tools to Living a Purposeful, Productive, and Happy Life

Does increased oxidative stress cause hypertension

Pinpointing Absorption Issues: Testing helps us determine if your body is failing to absorb B12 from food due to gut issues, age, or autoimmune conditions like pernicious anemia